Nasus Pharma Statistics
NYSE: NSRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.63+0.0048 (+0.13%)
Market open · Delayed 15 min · as of Oct 9, 11:10 AM ET
Nasus Pharma by the numbers
Nasus Pharma has a market capitalization of $42.6 million based on 11.71M shares outstanding. With trailing EPS of $-1.20, Nasus Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.1% above its 50-day average and 8.6% below its 200-day average.
Average daily trading volume is 16.02K shares, or about $58,233 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NSRX valuation vs. peer median
| Metric | NSRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $42.58M | $40.34M | +6% |
| Avg. volume | 16.02K | 370.93K | -96% |
Peer median across 8 companies: VERU, GRCE, SCYX, FLNA, IXHL, CPHI, HOWL, LITS.
Valuation
- Market cap
- $42.58M
- EPS (TTM)
- $-1.20
- Shares outstanding
- 11.71M
Price and trading
- Previous close
- 3.63
- Open
- 3.63
- Day range
- 3.53 – 3.63
- 52-week range
- 1.98 – 9.50
- 52-week change
- -50.07%
- Beta
- —
- Volume
- 3.63K
- Average volume
- 16.02K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 42.58M
- Eps
- -1.20
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.50
- Week52 Low
- 1.98
- Avg Volume
- 16,021.00
- Shares Outstanding
- 11.71M
- Ma50
- 3.63
- Ma200
- 3.98
- Pct From52w High
- -61.74%
- Pct From52w Low
- 83.58%